Sirolimus and ACE-inhibitors: a note of caution.
Burdese
Manuel
M
Rossetti
Maura
M
Guarena
Cesare
C
Consiglio
Valentina
V
Mezza
Elisabetta
E
Soragna
Giorgio
G
Gai
Massimo
M
Segoloni
Giuseppe Paolo
GP
Piccoli
Giorgina Barbara
GB
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D017257:Ramipril / Q000009:adverse effects / Q000627:therapeutic use; D020123:Sirolimus / Q000009:adverse effects / Q000627:therapeutic use*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D007166:Immunosuppressive Agents; D017257:Ramipril; D020123:Sirolimus